THANG PHAM: Open Payments
NPI 1295207447 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 51 payments from 11 companies in 2025. Trend: 2023 $2,370 · 2024 $2,817 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $373 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 10 | $270 |
| ABIOMED | 4 | $134 |
| Novo Nordisk Inc | 5 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $117 |
| Merck Sharp & Dohme LLC | 3 | $88 |
| HEARTFLOW, INC. | 4 | $86 |
| Lilly USA, LLC | 1 | $33 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| Amgen Inc. | 1 | $25 |
Products named: LEQVIO, LifeVest, JARDIANCE, VERQUVO, FFRct, Ozempic, MOUNJARO, OPSUMIT.
Industry payments across CA — which companies pay providers there.
